Found: 63
Select item for more details and to access through your institution.
Neuroimaging and Clinical Findings in Healthy Middle-Aged Adults With Mild Traumatic Brain Injury in the PREVENT Dementia Study.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2426774, doi. 10.1001/jamanetworkopen.2024.26774
- By:
- Publication type:
- Article
Texture‐based morphometry in relation to apolipoprotein ε4 genotype, ageing and sex in a midlife population.
- Published in:
- Human Brain Mapping, 2024, v. 45, n. 11, p. 1, doi. 10.1002/hbm.26798
- By:
- Publication type:
- Article
Investigating the brain's neurochemical profile at midlife in relation to dementia risk factors.
- Published in:
- Brain Communications, 2024, v. 6, n. 3, p. 1, doi. 10.1093/braincomms/fcae138
- By:
- Publication type:
- Article
The PREVENT dementia programme: baseline demographic, lifestyle, imaging and cognitive data from a midlife cohort study investigating risk factors for dementia.
- Published in:
- Brain Communications, 2024, v. 6, n. 3, p. 1, doi. 10.1093/braincomms/fcae189
- By:
- Publication type:
- Article
Feasibility and usability of remote monitoring in Alzheimer's disease.
- Published in:
- Digital Health, 2024, p. 1, doi. 10.1177/20552076241238133
- By:
- Publication type:
- Article
Entorhinal‐based path integration selectively predicts midlife risk of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 4, p. 2779, doi. 10.1002/alz.13733
- By:
- Publication type:
- Article
Dementia risk and thalamic nuclei volumetry in healthy midlife adults: the PREVENT Dementia study.
- Published in:
- Brain Communications, 2024, v. 6, n. 2, p. 1, doi. 10.1093/braincomms/fcae046
- By:
- Publication type:
- Article
APOE ɛ4 exacerbates age-dependent deficits in cortical microstructure.
- Published in:
- Brain Communications, 2024, v. 6, n. 1, p. 1, doi. 10.1093/braincomms/fcad351
- By:
- Publication type:
- Article
Sex differences in the associations between the risk for late‐life Alzheimer's disease, protective lifestyle factors and cognition in mid‐life: The PREVENT Dementia study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074791
- By:
- Publication type:
- Article
Brain age gap, dementia risk factors and cognition in middle age.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078359
- By:
- Publication type:
- Article
Fear and avoidance of memory loss: associations with cognitive, psychological and lifestyle factors in mid‐ and later life.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 22, p. 1, doi. 10.1002/alz.077942
- By:
- Publication type:
- Article
Augmented reality versus standard tests to assess cognition and function in early Alzheimer's disease.
- Published in:
- NPJ Digital Medicine, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s41746-023-00978-6
- By:
- Publication type:
- Article
Measuring the volume of Thalamic nuclei in cognitively unimpaired, middle‐aged individuals from the PREVENT‐Dementia cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075529
- By:
- Publication type:
- Article
Functional connectome‐based prediction of individual clinical and cognitive scores in midlife population with risk of dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074664
- By:
- Publication type:
- Article
Investigating the impact of APOE4 genotype on the association between cerebral blood flow and haematological properties in mid‐life adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076219
- By:
- Publication type:
- Article
Family history of dementia is associated with longer sleep duration and smaller volume of the thalamus in the PREVENT‐Dementia study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075276
- By:
- Publication type:
- Article
Cerebral microbleeds in traumatic brain injury associated with differential risk factors and clinical outcomes: the PREVENT‐Dementia study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074728
- By:
- Publication type:
- Article
Apoe ε4 exacerbates age‐dependent decline of cortical microstructural changes in cognitively normal midlife individuals: the PREVENT‐Dementia and ALFA studies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074608
- By:
- Publication type:
- Article
Investigating the impact of APOE4 genotype on the association between cerebral blood flow and haematological properties in mid‐life adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081709
- By:
- Publication type:
- Article
Family history of dementia is associated with longer sleep duration and smaller volume of the thalamus in the PREVENT‐Dementia study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081673
- By:
- Publication type:
- Article
Cerebral microbleeds in traumatic brain injury associated with differential risk factors and clinical outcomes: the PREVENT‐Dementia study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081658
- By:
- Publication type:
- Article
Apoe ε4 exacerbates age‐dependent decline of cortical microstructural changes in cognitively normal midlife individuals: the PREVENT‐Dementia and ALFA studies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081654
- By:
- Publication type:
- Article
Artificial intelligence for dementia prevention.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 12, p. 5952, doi. 10.1002/alz.13463
- By:
- Publication type:
- Article
Correction: Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Identification of preclinical dementia according to ATN classification for stratified trial recruitment: A machine learning approach.
- Published in:
- PLoS ONE, 2023, v. 18, n. 10, p. 1, doi. 10.1371/journal.pone.0288039
- By:
- Publication type:
- Article
Differential association of cerebral blood flow and anisocytosis in APOE ε4 carriers at midlife.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2023, v. 43, n. 10, p. 1672, doi. 10.1177/0271678X231173587
- By:
- Publication type:
- Article
Barriers to brain health behaviours: results from the Five Lives Brain Health Ireland Survey.
- Published in:
- Frontiers in Psychology, 2023, p. 1, doi. 10.3389/fpsyg.2023.1101514
- By:
- Publication type:
- Article
Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.
- Published in:
- PLoS ONE, 2023, v. 18, n. 7, p. 1, doi. 10.1371/journal.pone.0285807
- By:
- Publication type:
- Article
IPSC‐derived neurons with amyloid‐β treatment reflect features of Alzheimer's disease patients.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.065060
- By:
- Publication type:
- Article
Modifiable risk factors for dementia, and awareness of brain health behaviors: Results from the Five Lives Brain Health Ireland Survey (FLBHIS).
- Published in:
- Frontiers in Psychology, 2023, v. 13, p. 1, doi. 10.3389/fpsyg.2022.1070259
- By:
- Publication type:
- Article
ILiAD trial of levetiracetam.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.059599
- By:
- Publication type:
- Article
Identification of preclinical dementia according to ATN classification for stratified trial recruitment: A machine learning approach.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 7, p. 1, doi. 10.1002/alz.062184
- By:
- Publication type:
- Article
Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerability.
- Published in:
- Brain Communications, 2022, v. 4, n. 6, p. 1, doi. 10.1093/braincomms/fcac267
- By:
- Publication type:
- Article
Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01095-4
- By:
- Publication type:
- Article
Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 8, p. 4299, doi. 10.1007/s00415-022-11061-7
- By:
- Publication type:
- Article
Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis.
- Published in:
- Brain Communications, 2022, v. 4, n. 1, p. 1, doi. 10.1093/braincomms/fcab297
- By:
- Publication type:
- Article
Secondary Prevention of Dementia: Combining Risk Factors and Scalable Screening Technology.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.772836
- By:
- Publication type:
- Article
An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Remote monitoring technologies in Alzheimer's disease: design of the RADAR-AD study.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00825-4
- By:
- Publication type:
- Article
Continuous and risk‐score‐based predictors of ATN Alzheimer's disease status among cognitively healthy individuals: Findings from the EPAD‐LCS study: Neuroimaging / Optimal neuroimaging measures for early detection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041097
- By:
- Publication type:
- Article
Impact of APOE4 and future family history on early adulthood cardiovascular risk: Results from a 30‐year cohort study: Epidemiology / Innovative methods in epidemiology (i.e., assessment methods, design, recruitment strategies, statistical methods, etc.)
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040454
- By:
- Publication type:
- Article
Evaluation of [<sup>13</sup>N]ammonia positron emission tomography as a potential method for quantifying glutamine synthetase activity in the human brain.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13550-020-00731-0
- By:
- Publication type:
- Article
Correlation of Alzheimer's Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.230458
- By:
- Publication type:
- Article
Prediction of Alzheimer's disease biomarker status defined by the 'ATN framework' among cognitively healthy individuals: results from the EPAD longitudinal cohort study.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13195-020-00711-5
- By:
- Publication type:
- Article
Correlation of Alzheimer's Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.230458
- By:
- Publication type:
- Article
Correlation of Alzheimer's Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.230458
- By:
- Publication type:
- Article
Correlation of Alzheimer’s Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.230458
- By:
- Publication type:
- Article
P4‐605: STORY TIME: COMPUTATIONAL ANALYSIS OF RAW‐SPEECH TO AID THE DETECTION OF PRECLINICAL ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1556, doi. 10.1016/j.jalz.2019.08.153
- By:
- Publication type:
- Article
P4‐604: SMARTPHONE‐BASED ASSESSMENT OF EXECUTIVE FUNCTION: ANALYSING MOTOR‐RESPONSE TRAJECTORIES TO ENHANCE THE DETECTION OF PRECLINICAL COGNITIVE IMPAIRMENT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1556, doi. 10.1016/j.jalz.2019.08.152
- By:
- Publication type:
- Article